Latest Articles
Cyclana Bio raises £5m for endometriosis drug discovery - UKTN
Cyclana Bio raises £5m for endometriosis drug discovery UKTN
Published: Oct. 20, 2025, 1:13 p.m.
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis - Business Wire
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis Business Wire
Published: Oct. 20, 2025, 10:40 a.m.
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis - Technology Networks
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis Technology Networks
Published: Oct. 20, 2025, 10:32 a.m.
Universal Quantum Joins Open Quantum Institute for Endometriosis Drug Discovery via Quantum Computing - Quantum Computing Report
Universal Quantum Joins Open Quantum Institute for Endometriosis Drug Discovery via Quantum Computing Quantum Computing Report
Published: July 25, 2025, 12:21 a.m.
Universal Quantum Joins Open Quantum Institute to Advance Endometriosis Drug Discovery with Quantum Computing - The Quantum Insider
Universal Quantum Joins Open Quantum Institute to Advance Endometriosis Drug Discovery with Quantum Computing The Quantum Insider
Published: July 24, 2025, 11:14 a.m.
Drug Discovery Science Articles | Page 83 - Technology Networks
Drug Discovery Science Articles | Page 83 Technology Networks
Published: May 7, 2025, 11:32 a.m.
Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery - ACS Publications
Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery ACS Publications
Published: April 15, 2025, 1:03 p.m.
Macrophage reprogramming: new frontier in endometriosis - Drug Discovery & Development
Macrophage reprogramming: new frontier in endometriosis Drug Discovery & Development
Published: Oct. 16, 2024, 10:52 p.m.
P2X3 and P2X2/3 Receptors Inhibition Produces a Consistent Analgesic Efficacy: A Systematic Review and Meta-Analysis of Preclinical Studies.
P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate the …
Published: Oct. 9, 2024, midnight
Funding boosts endometriosis drug discovery efforts - Walter and Eliza Hall Institute of Medical Research
Funding boosts endometriosis drug discovery efforts Walter and Eliza Hall Institute of Medical Research
Published: July 19, 2024, 7 a.m.
Link copied to clipboard!